Ryan Jason
Director at WGS; Chief Financial Officer at Foundation Medicine, Inc.
- Sold, on record
- $19.1M
- Dollars the filings state
- Form 4 sales
- 43
- Latest Aug 27, 2025
- Form 144 notices
- 2
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- WGSGeneDx Holdings Corp.Director
- Foundation Medicine, Inc.Chief Financial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Foundation Medicine, Inc.226,109 shares
- WGS161,277 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Foundation Medicine, Inc.Plan not statedJul 2, 2018 2018
Sold 3,403 shares at $136.66 ($465k)
Ryan Jason, Chief Financial Officer
Sold 6.5% of holdings ($7.2M position)49,170 shares left0.7x usual sizeFiling
- 2 Form 4 sale WGSPlan not statedOct 17, 2022 +1568 days
Sold 1,281 shares at $0.86 ($1k)
Ryan Jason, Executive Chairman
Sold 7.5% of holdings ($15k position)15,833 shares leftFirst sale on recordFiling
- 3 Form 4 sale WGSUnusualDec 31, 2022 +75 days
Sold 73,732 shares at $0.26 ($19k)
Ryan Jason, Executive Chairman
Sold 28% of holdings ($68k position)189,626 shares leftFiling
- 4 Form 4 sale WGSNo planOct 17, 2023 +290 days
Sold 42 shares at $3.19 ($134)
Ryan Jason, Executive Chairman
No 10b5-1 planSold 0.7% of holdings ($19k position)5,834 shares leftFiling
- 5 Form 144 notice WGSNoticeNov 19, 2024 +399 days
Filed to sell 47,000 shares ($3.3M)
Ryan Jason, Officer
No 10b5-1 planFiling
- 6 Form 4 sale WGSUnusualNov 20, 2024 +1 day
Sold 47,000 shares at $70.57 ($3.3M)
Ryan Jason, Director
No 10b5-1 planSold 100% of holdings ($3.3M position)0 shares leftFollows a Form 144Filing
- 7 Form 4 sale WGSUnusualAug 27, 2025 +280 days
Sold 39,222 shares at $127.37 ($5M)
Ryan Jason, Director
No 10b5-1 planSold 27.5% of holdings ($18.2M position)103,284 shares leftFollows a Form 144Filing
- 8 Form 144 notice WGSNoticeAug 27, 2025 same day
Filed to sell 39,222 shares ($5M)
Ryan Jason, Director
No 10b5-1 planFiling
Every transaction
Loading transactions…
Sales and notices (45)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2025 | Aug 27, 2025 | WGS | Director | Form 144 notice | 39,222 | $5M | Notice | SEC | |
| Aug 27, 2025 | Aug 27, 2025 | WGS | Director | Form 4 sale | 39,222 | $5M | 27.5% | Unusual | SEC |
| Nov 20, 2024 | Nov 21, 2024 | WGS | Director | Form 4 sale | 47,000 | $3.3M | 100.0% | Unusual | SEC |
| Nov 19, 2024 | Nov 19, 2024 | WGS | Officer | Form 144 notice | 47,000 | $3.3M | Notice | SEC | |
| Oct 17, 2023 | Oct 18, 2023 | WGS | Executive Chairman | Form 4 sale | 42 | $134 | 0.7% | No plan | SEC |
| Dec 31, 2022 | Jan 4, 2023 | WGS | Executive Chairman | Form 4 sale | 73,732 | $19k | 28.0% | Unusual | SEC |
| Oct 17, 2022 | Oct 18, 2022 | WGS | Executive Chairman | Form 4 sale | 1,281 | $1k | 7.5% | Plan not stated | SEC |
| Jul 2, 2018 | Jul 5, 2018 | Foundation Medicine, Inc. | Chief Financial Officer | Form 4 sale | 3,403 | $465k | 6.5% | Plan not stated | SEC |
| Apr 16, 2018 | Apr 18, 2018 | Foundation Medicine, Inc. | Chief Financial Officer | Form 4 sale | 3,449 | $256k | 6.2% | Plan not stated | SEC |
| Apr 3, 2018 | Apr 5, 2018 | Foundation Medicine, Inc. | Chief Financial Officer | Form 4 sale | 1 | $72 | 0.0% | Plan not stated | SEC |
| Apr 2, 2018 | Apr 3, 2018 | Foundation Medicine, Inc. | Chief Financial Officer | Form 4 sale | 6,139 | $468k | 9.9% | Plan not stated | SEC |
| Mar 15, 2018 | Mar 19, 2018 | Foundation Medicine, Inc. | Chief Financial Officer | Form 4 sale | 15,000 | $1.2M | 23.4% | Unusual | SEC |
| Feb 15, 2018 | Feb 20, 2018 | Foundation Medicine, Inc. | Chief Financial Officer | Form 4 sale | 15,000 | $1M | 23.4% | Unusual | SEC |
| Jan 16, 2018 | Jan 18, 2018 | Foundation Medicine, Inc. | Chief Financial Officer | Form 4 sale | 21,035 | $1.4M | 29.9% | Unusual | SEC |
| Jan 2, 2018 | Jan 3, 2018 | Foundation Medicine, Inc. | Chief Financial Officer | Form 4 sale | 2,336 | $150k | 4.4% | Plan not stated | SEC |
| Dec 5, 2017 | Dec 7, 2017 | Foundation Medicine, Inc. | Chief Financial Officer | Form 4 sale | 21,726 | $1.3M | 29.2% | Unusual | SEC |
| Nov 2, 2017 | Nov 6, 2017 | Foundation Medicine, Inc. | Chief Financial Officer | Form 4 sale | 9,731 | $487k | 15.6% | Plan not stated | SEC |
| Oct 12, 2017 | Oct 16, 2017 | Foundation Medicine, Inc. | Chief Financial Officer | Form 4 sale | 1,152 | $52k | 1.8% | Plan not stated | SEC |
| Oct 2, 2017 | Oct 4, 2017 | Foundation Medicine, Inc. | Chief Financial Officer | Form 4 sale | 3,154 | $122k | 4.7% | Plan not stated | SEC |
| Jul 13, 2017 | Jul 17, 2017 | Foundation Medicine, Inc. | Chief Financial Officer | Form 4 sale | 5,084 | $202k | 7.1% | Plan not stated | SEC |
| Jul 6, 2017 | Jul 7, 2017 | Foundation Medicine, Inc. | Chief Financial Officer | Form 4 sale | 6,683 | $260k | 8.5% | Plan not stated | SEC |
| Jun 2, 2017 | Jun 6, 2017 | Foundation Medicine, Inc. | Chief Financial Officer | Form 4 sale | 5,573 | $223k | 6.6% | Unusual | SEC |
| Apr 18, 2017 | Apr 20, 2017 | Foundation Medicine, Inc. | Chief Financial Officer | Form 4 sale | 503 | $17k | 1.0% | Plan not stated | SEC |
| Apr 3, 2017 | Apr 5, 2017 | Foundation Medicine, Inc. | Chief Financial Officer | Form 4 sale | 1,233 | $39k | 2.3% | Plan not stated | SEC |
| Mar 16, 2017 | Mar 20, 2017 | Foundation Medicine, Inc. | Chief Financial Officer | Form 4 sale | 12,500 | $396k | 19.1% | Unusual | SEC |
| Jan 13, 2017 | Jan 18, 2017 | Foundation Medicine, Inc. | Chief Financial Officer | Form 4 sale | 1,777 | $34k | 3.2% | Plan not stated | SEC |
| Jan 4, 2017 | Jan 5, 2017 | Foundation Medicine, Inc. | Chief Financial Officer | Form 4 sale | 4,665 | $83k | 7.9% | Plan not stated | SEC |
| Oct 20, 2016 | Oct 24, 2016 | Foundation Medicine, Inc. | Chief Financial Officer | Form 4 sale | 506 | $11k | 0.8% | Plan not stated | SEC |
| Oct 4, 2016 | Oct 5, 2016 | Foundation Medicine, Inc. | Chief Financial Officer | Form 4 sale | 1,220 | $29k | 2.0% | Plan not stated | SEC |
| Aug 19, 2016 | Aug 23, 2016 | Foundation Medicine, Inc. | Chief Financial Officer | Form 4 sale | 13,863 | $332k | 18.5% | Unusual | SEC |
| Jul 5, 2016 | Jul 6, 2016 | Foundation Medicine, Inc. | Chief Financial Officer | Form 4 sale | 4,687 | $83k | 6.3% | Plan not stated | SEC |
| Feb 27, 2015 | Mar 3, 2015 | Foundation Medicine, Inc. | Senior Vice President, Finance | Form 4 sale | 25,000 | $1.2M | 100.0% | Unusual | SEC |
| Dec 15, 2014 | Dec 17, 2014 | Foundation Medicine, Inc. | Senior Vice President, Finance | Form 4 sale | 2,361 | $51k | 100.0% | Unusual | SEC |
| Nov 17, 2014 | Nov 19, 2014 | Foundation Medicine, Inc. | Senior Vice President, Finance | Form 4 sale | 3,541 | $88k | 100.0% | Unusual | SEC |
| Oct 27, 2014 | Oct 29, 2014 | Foundation Medicine, Inc. | Senior Vice President, Finance | Form 4 sale | 2,360 | $59k | 100.0% | Unusual | SEC |
| Oct 15, 2014 | Oct 17, 2014 | Foundation Medicine, Inc. | Senior Vice President, Finance | Form 4 sale | 2,361 | $47k | 100.0% | Unusual | SEC |
| Sep 15, 2014 | Sep 16, 2014 | Foundation Medicine, Inc. | Senior Vice President, Finance | Form 4 sale | 2,361 | $52k | 100.0% | Unusual | SEC |
| Aug 15, 2014 | Aug 19, 2014 | Foundation Medicine, Inc. | Senior Vice President, Finance | Form 4 sale | 3,541 | $89k | 100.0% | Unusual | SEC |
| Jul 15, 2014 | Jul 17, 2014 | Foundation Medicine, Inc. | Senior Vice President, Finance | Form 4 sale | 3,541 | $96k | 100.0% | Unusual | SEC |
| Jun 26, 2014 | Jun 30, 2014 | Foundation Medicine, Inc. | Senior Vice President, Finance | Form 4 sale | 1,180 | $30k | 100.0% | Unusual | SEC |
| Jun 16, 2014 | Jun 18, 2014 | Foundation Medicine, Inc. | Senior Vice President, Finance | Form 4 sale | 2,361 | $53k | 100.0% | Unusual | SEC |
| Jun 9, 2014 | Jun 12, 2014 | Foundation Medicine, Inc. | Senior Vice President, Finance | Form 4 sale | 1,180 | $30k | 100.0% | Unusual | SEC |
| Jun 5, 2014 | Jun 6, 2014 | Foundation Medicine, Inc. | Senior Vice President, Finance | Form 4 sale | 10,000 | $241k | 100.0% | Unusual | SEC |
| May 15, 2014 | May 19, 2014 | Foundation Medicine, Inc. | Senior Vice President, Finance | Form 4 sale | 2,361 | $49k | 100.0% | Unusual | SEC |
| Apr 16, 2014 | Apr 18, 2014 | Foundation Medicine, Inc. | Senior Vice President, Finance | Form 4 sale | 3,541 | $93k | 100.0% | Unusual | SEC |